224 related articles for article (PubMed ID: 19650154)
1. Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example.
Rawson NS
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1072-9. PubMed ID: 19650154
[TBL] [Abstract][Full Text] [Related]
2. Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.
Paterson JM; Laupacis A; Bassett K; Anderson GM;
Health Aff (Millwood); 2006; 25(5):1436-43. PubMed ID: 16966744
[TBL] [Abstract][Full Text] [Related]
3. How many physicians does Canada need to care for our aging population?
Roos NP; Bradley JE; Fransoo R; Shanahan M
CMAJ; 1998 May; 158(10):1275-84. PubMed ID: 9614820
[TBL] [Abstract][Full Text] [Related]
4. Record linkage for pharmacoepidemiological studies in cancer patients.
Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
[TBL] [Abstract][Full Text] [Related]
5. Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data.
Rawson NS
Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):607-12. PubMed ID: 11980248
[TBL] [Abstract][Full Text] [Related]
6. Cross-provincial use of cardiac services: the importance of data-sharing for clinical registries and outcomes research.
Humphries KH; Carere RG; Izadnegahdar M; Galbraith PD; Knudtson ML; Ghali WA
Can J Cardiol; 2005 Mar; 21(3):267-72. PubMed ID: 15776116
[TBL] [Abstract][Full Text] [Related]
7. A survey of population-based drug databases in Canada.
Miller E; Blatman B; Einarson TR
CMAJ; 1996 Jun; 154(12):1855-64. PubMed ID: 8653645
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
[TBL] [Abstract][Full Text] [Related]
10. The Nordic countries as a cohort for pharmacoepidemiological research.
Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
[TBL] [Abstract][Full Text] [Related]
11. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.
Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E
Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558
[TBL] [Abstract][Full Text] [Related]
12. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
Hanley GE; Morgan S
Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
Cooke C; Nissen L; Sketris I; Tett SE
Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
[TBL] [Abstract][Full Text] [Related]
14. In-hospital outcomes after percutaneous coronary intervention in Canada: 1992/93 to 2000/01.
Jamal SM; Shrive FM; Ghali WA; Knudtson ML; Eisenberg MJ;
Can J Cardiol; 2003 Jun; 19(7):782-9. PubMed ID: 12813611
[TBL] [Abstract][Full Text] [Related]
15. Provincial disparities of growth hormone coverage for young adult survivors of paediatric brain tumours across Canada.
Hasan H; Howard F; Morgan SG; Metzger DL; Lo AC; Goddard K; Gill S; Johnson M
Healthc Policy; 2014 Feb; 9(3):80-96. PubMed ID: 24726076
[TBL] [Abstract][Full Text] [Related]
16. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic status, access to health care, and outcomes after acute myocardial infarction in Canada's universal health care system.
Pilote L; Tu JV; Humphries K; Behouli H; Belisle P; Austin PC; Joseph L
Med Care; 2007 Jul; 45(7):638-46. PubMed ID: 17571012
[TBL] [Abstract][Full Text] [Related]
18. How complete are drug history profiles that are based on public drug benefit claims?
Paterson JM; Suleiman A; Hux JE; Bell C
Can J Clin Pharmacol; 2008; 15(1):e108-16. PubMed ID: 18283220
[TBL] [Abstract][Full Text] [Related]
19. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database.
Bérard A; Lacasse A
Can J Clin Pharmacol; 2009; 16(2):e360-9. PubMed ID: 19553702
[TBL] [Abstract][Full Text] [Related]
20. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
Noize P; Bazin F; Dufouil C; Lechevallier-Michel N; Ancelin ML; Dartigues JF; Tzourio C; Moore N; Fourrier-Réglat A
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):310-9. PubMed ID: 19241438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
